CIP
MACK

Convergence Investment Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Convergence Investment Partners’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,276
Closed -$493K – 448
2015
Q1 		$493K Sell
5,276
-9,072
-63% -$848K 0.07% 314
2014
Q4 		$1.28M Buy
+14,348
New +$1.28M 0.17% 208